BARTOLINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.788
NA - Nord America 15.280
AS - Asia 5.444
SA - Sud America 734
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 150
OC - Oceania 139
Totale 40.712
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.024
PL - Polonia 11.365
RU - Federazione Russa 2.261
IT - Italia 1.645
SG - Singapore 1.523
CN - Cina 1.295
SE - Svezia 741
HK - Hong Kong 704
VN - Vietnam 682
IE - Irlanda 670
BR - Brasile 601
UA - Ucraina 508
KR - Corea 485
DE - Germania 453
FI - Finlandia 326
GB - Regno Unito 312
FR - Francia 276
IN - India 161
CA - Canada 143
AU - Australia 136
ID - Indonesia 108
JP - Giappone 92
TR - Turchia 92
NL - Olanda 65
BD - Bangladesh 60
JO - Giordania 50
AR - Argentina 45
CI - Costa d'Avorio 42
MX - Messico 39
IQ - Iraq 35
SC - Seychelles 34
PT - Portogallo 27
ES - Italia 24
ZA - Sudafrica 23
CH - Svizzera 22
CO - Colombia 22
PK - Pakistan 22
BE - Belgio 21
SA - Arabia Saudita 18
MA - Marocco 16
TH - Thailandia 15
EC - Ecuador 14
NG - Nigeria 14
AT - Austria 13
CR - Costa Rica 13
AZ - Azerbaigian 12
JM - Giamaica 12
PE - Perù 12
PY - Paraguay 12
EG - Egitto 11
LT - Lituania 11
NP - Nepal 11
PR - Porto Rico 11
VE - Venezuela 11
PH - Filippine 9
TN - Tunisia 9
UZ - Uzbekistan 9
CL - Cile 8
IL - Israele 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
GT - Guatemala 7
KE - Kenya 7
RO - Romania 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
TT - Trinidad e Tobago 6
AL - Albania 5
HN - Honduras 5
LB - Libano 5
MY - Malesia 5
OM - Oman 5
BH - Bahrain 4
BJ - Benin 4
ET - Etiopia 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
UY - Uruguay 4
AM - Armenia 3
AO - Angola 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IR - Iran 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BS - Bahamas 2
EE - Estonia 2
GP - Guadalupe 2
IS - Islanda 2
MD - Moldavia 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
Totale 40.548
Salva come PNG Salva come JPEG
Città #
Warsaw 11.357
Santa Clara 1.996
Ashburn 1.885
Fairfield 1.092
Singapore 1.065
Jacksonville 749
Dublin 666
San Jose 635
Chandler 607
Hong Kong 566
Woodbridge 507
Seattle 483
Council Bluffs 461
Cambridge 459
Wilmington 409
Houston 390
Seoul 390
Milan 357
Beijing 287
Hefei 261
The Dalles 240
Dong Ket 223
Los Angeles 205
Altamura 170
Princeton 168
Ann Arbor 165
Buffalo 164
Boardman 154
Phoenix 151
Dallas 139
Lawrence 138
Ho Chi Minh City 129
Lauterbourg 129
Helsinki 125
Boston 123
Rome 115
Hanoi 111
Melbourne 109
Mumbai 105
Paris 97
Jakarta 94
San Diego 94
New York 88
Tokyo 83
Medford 74
Moscow 73
Seongnam 73
Munich 70
Shanghai 68
Izmir 62
Columbus 61
Florence 61
Chicago 57
Washington 57
Falls Church 55
São Paulo 50
Springfield 47
Kent 44
Abidjan 42
Turin 39
London 36
Naples 35
Frankfurt am Main 34
Guangzhou 33
Orem 33
Figino 32
Montreal 31
Philadelphia 31
Atlanta 28
Hillsboro 28
Turku 28
Brooklyn 27
San Francisco 27
Frankfurt Am Main 26
Norwalk 26
Auburn Hills 25
Palermo 24
Verona 24
West Jordan 24
Amsterdam 23
Denver 23
Las Vegas 21
Bern 20
Bologna 20
Brussels 20
Redondo Beach 20
Groningen 19
Miano 19
Tianjin 19
Toronto 19
Andover 18
Dearborn 18
North Bergen 18
Boydton 17
Baghdad 16
Bari 16
Guimarães 16
Zhengzhou 15
Da Nang 14
Yubileyny 14
Totale 29.811
Salva come PNG Salva come JPEG
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 722
M1 receptor activation is a requirement for arecoline analgesia. 657
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 541
Antinociceptive property of the nicotinic agonist AG4 in rodents 537
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 501
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 450
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 445
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 432
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 429
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 411
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 408
Ryanodine receptors are involved in muscarinic antinociception in mice. 406
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 406
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 403
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 397
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 387
Local anaesthetic activity of beta-caryophyllene. 377
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 372
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 368
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 367
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 355
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 352
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 352
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 349
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 348
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 346
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 341
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 340
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 339
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 336
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 335
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 332
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 332
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 329
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 329
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 329
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 327
Role of intracellular calcium in acute thermal pain perception 327
Effect of K+ channel modulation on mouse feeding behaviour 324
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 323
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 323
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 323
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 320
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 317
Prochlorperazine induces central antinociception mediated by the muscarinic system. 315
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 314
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 313
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 313
Influence of potassium channel modulators on cognitive processes in mice 311
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 311
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 311
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 310
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 310
Caffeine induces central cholinergic analgesia. 310
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 310
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 309
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 308
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 308
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 308
Memory facilitation with atropine: a paradoxical effect 307
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 306
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 304
Endogenous morphine modulates acute thermonociception in mice. 304
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 300
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 299
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 299
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 298
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 296
In vitro characterization of a novel, potent and selective M3 antagonist 296
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 296
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 289
Neuropathy-induced apoptosis: Protective effect of physostigmine 289
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 287
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 286
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 286
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 284
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 281
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 273
Antagonism by piracetam of baclofen antinociception 267
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 262
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 260
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 257
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 254
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 252
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 248
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 230
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 223
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram). 222
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 221
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 217
Gi/o proteins: expression for direct activation enquiry 205
S-(-)-ET126: a potent and selective M1 antagonist 205
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 203
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 201
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 196
R-(+)-HYOSCYAMINE: A PERIPHERAL CHOLINERGIC AMPLIFER 194
INVOLVEMENT OF CENTRAL CHOLINERGIC NEUROTRANSMISSION IN METOCLOPRAMIDE ANALGESIA 193
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 192
Role of histamine in rodent antinociception 192
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 191
Totale 32.170
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.006 0 0 0 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.453 57 132 219 72 81 228 48 449 29 49 45 44
2024/20256.621 241 684 416 892 1.815 824 134 368 299 273 430 245
2025/20268.599 834 1.098 673 422 852 442 1.012 468 584 668 429 1.117
2026/20271.969 335 489 843 302 0 0 0 0 0 0 0 0
Totale 40.712